Insider Transactions in Q1 2022 at Clover Health Investments, Corp. (CLOV)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Prabhdeep Singh Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
255,474
+32.97%
|
-
|
|
Mar 14
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
510,948
+40.6%
|
-
|
|
Mar 14
2022
|
Joseph Richards Martin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,100,775
+50.0%
|
-
|
|
Mar 11
2022
|
Lee Shapiro Director |
BUY
Open market or private purchase
|
Direct |
80,000
+42.76%
|
$240,000
$3.1 P/Share
|
|
Mar 03
2022
|
Chelsea Clinton Director |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$200,000
$2.53 P/Share
|
|
Jan 31
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
15,771
+6.25%
|
-
|
|
Jan 07
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
15,830
-1.09%
|
$47,490
$3.16 P/Share
|
|
Jan 07
2022
|
Lee Shapiro Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+50.0%
|
-
|
|
Jan 07
2022
|
William G Robinson Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+50.0%
|
-
|
|
Jan 07
2022
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,664,825
-49.8%
|
$4,994,475
$3.16 P/Share
|
|
Jan 07
2022
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,342,698
+50.0%
|
-
|